Evolving treatment strategies in CML - moving from early and deep molecular responses to TKI discontinuation and treatment-free remission: is there a need for longer-term trial outcomes?

被引：9
作者：
Eskazan, Ahmet Emre [1 ]
机构：
[1] Istanbul Univ, Div Hematol, Dept Internal Med, Cerrahpasa Fac Med, Istanbul, Turkey
来源：
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 2018年 / 84卷 / 08期
关键词：
chronic myeloid leukaemia; deep molecular response; discontinuation; early molecular response; treatment-free remission; tyrosine kinase inhibitor; CHRONIC MYELOID-LEUKEMIA; TYROSINE KINASE INHIBITORS; CHRONIC-PHASE; ADVERSE EVENTS; IMATINIB; NILOTINIB; DASATINIB; BOSUTINIB; THERAPY; DISEASE;
D O I：
10.1111/bcp.13637
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：1635 / 1638
页数：4
相关论文
共 33 条
[1]   The price of drugs for chronic myeloid leukemia (CML) is a reflection of the unsustainable prices of cancer drugs: from the perspective of a large group of CML experts [J].
Abboud, Camille ;
Berman, Ellin ;
Cohen, Adam ;
Cortes, Jorge ;
DeAngelo, Daniel ;
Deininger, Michael ;
Devine, Steven ;
Druker, Brian ;
Fathi, Amir ;
Jabbour, Elias ;
Jagasia, Madan ;
Kantarjian, Hagop ;
Khoury, Jean ;
Laneuville, Pierre ;
Larson, Richard ;
Lipton, Jeffrey ;
Moore, Joseph O. ;
Mughal, Tariq ;
O'Brien, Susan ;
Pinilla-Ibarz, Javier ;
Quintas-Cardama, Alfonso ;
Radich, Jerald ;
Reddy, Vishnu ;
Schiffer, Charles ;
Shah, Neil ;
Shami, Paul ;
Silver, Richard T. ;
Snyder, David ;
Stone, Richard ;
Talpaz, Moshe ;
Tefferi, Ayalew ;
Van Etten, Richard A. ;
Wetzler, Meir ;
Abruzzese, Elisabetta ;
Apperley, Jane ;
Breccia, Massimo ;
Byrne, Jenny ;
Cervantes, Francisco ;
Chelysheva, Ekaterina ;
Clark, R. E. ;
de Lavallade, Hugues ;
Dyagil, Iryna ;
Gambacorti-Passerini, Carlo ;
Goldman, John ;
Haznedaroglu, Ibrahim ;
Hjorth-Hansen, Henrik ;
Holyoake, Tessa ;
Huntly, Brian ;
le Coutre, Philipp ;
Lomaia, Elza .
BLOOD, 2013, 121 (22) :4439-4442
[2]  
[Anonymous], ASH ANN M
[3]   Oral antineoplastic agents: how do we care about adherence? [J].
Barillet, Marie ;
Prevost, Virginie ;
Joly, Florence ;
Clarisse, Benedicte .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2015, 80 (06) :1289-1302
[4]   Life Expectancy of Patients With Chronic Myeloid Leukemia Approaches the Life Expectancy of the General Population [J].
Bower, Hannah ;
Bjorkholm, Magnus ;
Dickman, Paul W. ;
Hoglund, Martin ;
Lambert, Paul C. ;
Andersson, Therese M. -L. .
JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (24) :2851-+
[5]   A Phase 2 Trial of Ponatinib in Philadelphia Chromosome-Positive Leukemias [J].
Cortes, J. E. ;
Kim, D. -W. ;
Pinilla-Ibarz, J. ;
le Coutre, P. ;
Paquette, R. ;
Chuah, C. ;
Nicolini, F. E. ;
Apperley, J. F. ;
Khoury, H. J. ;
Talpaz, M. ;
DiPersio, J. ;
DeAngelo, D. J. ;
Abruzzese, E. ;
Rea, D. ;
Baccarani, M. ;
Mueller, M. C. ;
Gambacorti-Passerini, C. ;
Wong, S. ;
Lustgarten, S. ;
Rivera, V. M. ;
Clackson, T. ;
Turner, C. D. ;
Haluska, F. G. ;
Guilhot, F. ;
Deininger, M. W. ;
Hochhaus, A. ;
Hughes, T. ;
Goldman, J. M. ;
Shah, N. P. ;
Kantarjian, H. .
NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (19) :1783-1796
[6]   Bosutinib Versus Imatinib for Newly Diagnosed Chronic Myeloid Leukemia: Results From the Randomized BFORE Trial [J].
Cortes, Jorge E. ;
Gambacorti-Passerini, Carlo ;
Deininger, Michael W. ;
Mauro, Michael J. ;
Chuah, Charles ;
Kim, Dong-Wook ;
Dyagil, Irina ;
Glushko, Nataliia ;
Milojkovic, Dragana ;
le Coutre, Philipp ;
Garcia-Gutierrez, Valentin ;
Reilly, Laurence ;
Jeynes-Ellis, Allison ;
Leip, Eric ;
Bardy-Bouxin, Nathalie ;
Hochhaus, Andreas ;
Brummendorf, Tim H. .
JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (03) :231-+
[7]   Final 5-Year Study Results of DASISION: The Dasatinib Versus Imatinib Study in Treatment-Naive Chronic Myeloid Leukemia Patients Trial [J].
Cortes, Jorge E. ;
Saglio, Giuseppe ;
Kantarjian, Hagop M. ;
Baccarani, Michele ;
Mayer, Jiri ;
Boque, Concepcion ;
Shah, Neil P. ;
Chuah, Charles ;
Casanova, Luis ;
Bradley-Garelik, Brigid ;
Manos, George ;
Hochhaus, Andreas .
JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (20) :2333-U54
[8]   Bosutinib Versus Imatinib in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia: Results From the BELA Trial [J].
Cortes, Jorge E. ;
Kim, Dong-Wook ;
Kantarjian, Hagop M. ;
Bruemmendorf, Tim H. ;
Dyagil, Irina ;
Griskevicius, Laimonas ;
Malhotra, Hemant ;
Powell, Christine ;
Gogat, Karin ;
Countouriotis, Athena M. ;
Gambacorti-Passerini, Carlo .
JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (28) :3486-3492
[9]   Deep molecular responses for treatment-free remission in chronic myeloid leukemia [J].
Dulucq, Stephanie ;
Mahon, Francois-Xavier .
CANCER MEDICINE, 2016, 5 (09) :2398-2411
[10]   Tyrosine kinase inhibitor (TKI) therapy for newly-diagnosed patients with chronic myeloid leukemia: focusing on TKI discontinuation due to adverse events - is better always good? [J].
Eskazan, Ahmet Emre ;
Ozmen, Deniz .
EXPERT REVIEW OF HEMATOLOGY, 2017, 10 (07) :583-586
1234